Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
BUZDAR, AMAN U
One or more keywords matched the following items that are connected to BUZDAR, AMAN U
Item TypeName
Academic Article Positron emission tomography using [18F]fluorotamoxifen to evaluate therapeutic responses in patients with breast cancer: preliminary study.
Academic Article Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
Academic Article Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
Academic Article Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.
Academic Article Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials.
Academic Article Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
Academic Article Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer.
Academic Article Is there a role for adjuvant tamoxifen in progesterone receptor-positive breast cancer? An in silico clinical trial.
Academic Article Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.
Concept Estrogen Receptor Modulators
Concept Estrogen Antagonists
Concept Estrogen Receptor beta
Concept Receptors, Estrogen
Concept Estrogens
Concept Selective Estrogen Receptor Modulators
Concept Estrogen Receptor alpha
Academic Article Hormone receptors in breast cancer and response to chemotherapy.
Academic Article Estrogen therapy and metastatic breast cancer.
Academic Article Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.
Academic Article Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs.
Academic Article Results of adjuvant chemotherapy trials in breast cancer at M. D. Anderson Hospital and Tumor Institute.
Academic Article Aromatase inhibitors: current status.
Academic Article Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Academic Article Update on endocrine therapy for breast cancer.
Academic Article Anastrozole (Arimidex), a new aromatase inhibitor for advanced breast cancer: mechanism of action and role in management.
Academic Article The place of chemotherapy in the treatment of early breast cancer.
Academic Article Tamoxifen's clinical applications: old and new.
Academic Article Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.
Academic Article Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy.
Academic Article TAS-108: a novel steroidal antiestrogen.
Academic Article Tamoxifen versus aromatase inhibitors for breast cancer prevention.
Academic Article Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors.
Academic Article Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study.
Academic Article Sequential cyclic combined hormonal therapy for metastatic breast cancer.
Academic Article Phase II evaluation of Ly156758 in metastatic breast cancer.
Academic Article The management of locally advanced breast cancer: a combined modality approach.
Academic Article Hormonal therapy for metastatic male breast cancer.
Academic Article Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer.
Academic Article Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy.
Academic Article Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Academic Article Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCL, in metastatic breast cancer.
Academic Article Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
Academic Article Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer.
Academic Article Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer.
Academic Article Breast cancer in men.
Academic Article Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience.
Academic Article A review of adjuvant hormonal therapy in breast cancer.
Academic Article Fulvestrant: a new type of estrogen receptor antagonist for the treatment of advanced breast cancer.
Academic Article Safety, tolerability, and pharmacokinetics of TAS-108 in normal healthy post-menopausal female subjects: a phase I study on single oral dose.
Academic Article Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.
Academic Article Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.
Academic Article Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers.
Academic Article Fulvestrant--a novel estrogen receptor antagonist for the treatment of advanced breast cancer.
Academic Article Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer.
Academic Article Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer.
Academic Article Anastrozole.
Academic Article Predictive algorithms for adjuvant therapy: TransATAC.
Academic Article The sequential use of endocrine treatment for advanced breast cancer: where are we?
Academic Article Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.
Academic Article Current status of endocrine treatment of carcinoma of the breast.
Academic Article Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients.
Academic Article Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer.
Academic Article Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer.
Academic Article Trioxifene mesylate in the treatment of advanced breast cancer.
Academic Article Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer.
Academic Article Estrogen receptor: a prognostic factor in breast cancer.
Academic Article Imaging, biodistribution and therapy potential of halogenated tamoxifen analogues.
Academic Article Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support.
Academic Article Phase I trial of droloxifene in patients with metastatic breast cancer.
Academic Article Complete estrogen blockade for the treatment of metastatic and early stage breast cancer.
Academic Article Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.
Academic Article Preliminary data from ongoing adjuvant aromatase inhibitor trials.
Academic Article A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: final analysis with 10-year follow-up.
Academic Article The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women.
Academic Article How rapidly do oncologists respond to clinical trial data?
Academic Article TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
Academic Article Women age < or = 35 years with primary breast carcinoma: disease features at presentation.
Academic Article Are aromatase inhibitors superior to antiestrogens?
Academic Article Fulvestrant: pharmacologic profile versus existing endocrine agents for the treatment of breast cancer.
Academic Article Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.
Academic Article Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.
Academic Article Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy.
Academic Article Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.
Academic Article Randomized double-blind phase 2 trial of 3 doses of TAS-108 in patients with advanced or metastatic postmenopausal breast cancer.
Academic Article Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.
Academic Article Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group.
Academic Article Combination endocrine therapy in the management of breast cancer.
Academic Article Estrogen receptors and distinct patterns of breast cancer relapse.
Academic Article Distribution of (7alpha)-21-[4-[(diethylamino) methyl]-2-methoxyphenoxy]-7-methyl-19-norpregna-1,3,5(10)-trien-3-ol-20-[14C]2-hydroxy-1,2,3-propanetricarboxylate ([14C]TAS-108) and its metabolites after single oral administration to rats bearing 7,12-dimethylbenz(alpha)anthracene-induced mammary tumor.
Academic Article Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Academic Article Combination endocrine treatments unproven in breast cancer.
Academic Article Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.
Academic Article Differences in toxicity findings for antiestrogens.
Academic Article Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay.
Academic Article Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support.
Academic Article Complete remission with combination chemotherapy in metastatic breast carcinoma.
Academic Article Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
Academic Article Meta-analysis: selective estrogen-receptor modulators reduce breast cancer incidence.
Academic Article Which threshold for ER positivity? a retrospective study based on 9639 patients.
Academic Article Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole.
Academic Article Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
Academic Article Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer.
Academic Article Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.
Academic Article Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole
Academic Article Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426).
Academic Article Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2.
Academic Article Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.
Academic Article Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.
Search Criteria
  • Estrogens